Company: LHI
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006939
Chunk: 112

Company: Living Homeopathy International Ltd.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 112
---
 the amount of $687,495 and $1,433,143 for the years ended March 31, 2024 and 2023.

On a recurring basis, the primary future cash needs of the Company will be focused on our working capital, capital expenditures, investment, regulatory and compliance costs. We believe that our existing resources, including cash generated from operations, will be sufficient to meet our working capital requirement for our current operating and capital expenditure needs and obligations over the next twelve months. In order to fully implement its business plan and sustain continued growth, the Company may also need to raise capital from equity and debt financings.

Cash flows

The following table sets forth summary of our cash flows for the years ended March 31, 2024 and 2023, respectively.

|                                         |     | For the years 
 ended         
 March         
 31,           |      2024 |   |     |   |       2023 |   |
|:----------------------------------------|:----|:--------------|----------:|:--|:----|:--|-----------:|:--|
| Net cash generated from operating       
 activities                              |     | $             |   687,495 |   |     | $ |  1,403,676 |   |
| Net cash used in investing activities   |     |               |         - |   |     |   |          - |   |
| Net cash used in financing              
 activities                              |     |               |  (574,414 | ) |     |   | (3,224,882 | ) |
| Net increase (decrease) in cash         |     |               |   113,081 |   |     |   | (1,821,206 | ) |
| Effect of exchange rate changes on cash |     |               |     6,655 |   |     |   |     (8,473 | ) |
| Cash and cash equivalents               
 at the beginning of the year            |     |               | 2,195,190 |   |     |   |  4,024,869 |   |
| Cash and cash equivalents               
 at the end of the year                  |     | $             | 2,314,926 |   |     | $ |  2,195,190 |   |

Net cash generated from operating activities

Net cash generated from operating activities was $687,495 and $1,403,676 for the years ended March 31, 2024 and